289 related articles for article (PubMed ID: 10634404)
1. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.
Falorni A; Calcinaro F
Ann N Y Acad Sci; 2002 Apr; 958():99-106. PubMed ID: 12021088
[TBL] [Abstract][Full Text] [Related]
3. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
[TBL] [Abstract][Full Text] [Related]
4. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
[TBL] [Abstract][Full Text] [Related]
5. Epitope-restricted 65-kilodalton glutamic acid decarboxylase autoantibodies among new-onset Sardinian type 2 diabetes patients define phenotypes of autoimmune diabetes.
Maioli M; Alejandro E; Tonolo G; Gilliam LK; Bekris L; Hampe CS; Obinu DA; Manconi A; Puddu L; Lynch K; Lernmark A;
J Clin Endocrinol Metab; 2004 Nov; 89(11):5675-82. PubMed ID: 15531528
[TBL] [Abstract][Full Text] [Related]
6. Association of amino-terminal-specific antiglutamate decarboxylase (GAD65) autoantibodies with beta-cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis-prone diabetes mellitus.
Hampe CS; Nalini R; Maldonado MR; Hall TR; Garza G; Iyer D; Balasubramanyam A
J Clin Endocrinol Metab; 2007 Feb; 92(2):462-7. PubMed ID: 17090641
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
Hampe CS; Hall TR; Agren A; Rolandsson O
Clin Exp Immunol; 2007 Apr; 148(1):72-8. PubMed ID: 17286757
[TBL] [Abstract][Full Text] [Related]
8. Multiplicity of the antibody response to GAD65 in Type I diabetes.
Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
[TBL] [Abstract][Full Text] [Related]
10. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.
Reijonen H; Daniels TL; Lernmark A; Nepom GT
Diabetes; 2000 Oct; 49(10):1621-6. PubMed ID: 11016444
[TBL] [Abstract][Full Text] [Related]
11. GAD65 autoantibody responses in Japanese latent autoimmune diabetes in adult patients.
Maruyama T; Oak S; Shimada A; Hampe CS
Diabetes Care; 2008 Aug; 31(8):1602-7. PubMed ID: 18487477
[TBL] [Abstract][Full Text] [Related]
12. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
[TBL] [Abstract][Full Text] [Related]
13. Species-specific autoantibodies in type 1 diabetes.
Hampe CS; Ortqvist E; Rolandsson O; Landin-Olsson M; Törn C; Agren A; Persson B; Schranz DB; Lernmark A
J Clin Endocrinol Metab; 1999 Feb; 84(2):643-8. PubMed ID: 10022431
[TBL] [Abstract][Full Text] [Related]
14. Stable GAD65 autoantibody epitope patterns in type 1 diabetes children five years after onset.
Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Persson B; Lernmark A
J Autoimmun; 2002 Feb; 18(1):49-53. PubMed ID: 11869046
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12.
Achenbach P; Hawa MI; Krause S; Lampasona V; Jerram ST; Williams AJK; Bonifacio E; Ziegler AG; Leslie RD;
Diabetologia; 2018 Jul; 61(7):1644-1649. PubMed ID: 29619531
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
Rattarasarn C; Diosdado MA
Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
[TBL] [Abstract][Full Text] [Related]
17. Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity.
Jin P; Huang G; Lin J; Luo S; Zhou Z
Acta Diabetol; 2011 Jun; 48(2):149-55. PubMed ID: 21212992
[TBL] [Abstract][Full Text] [Related]
18. Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
Ronkainen MS; Hoppu S; Korhonen S; Simell S; Veijola R; Ilonen J; Simell O; Knip M
Eur J Endocrinol; 2006 Oct; 155(4):633-42. PubMed ID: 16990664
[TBL] [Abstract][Full Text] [Related]
19. Masked and overt autoantibodies specific to the DPD epitope of 65-kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved β-cell functional reserve in ketosis-prone diabetes.
Oak S; Gaur LK; Radtke J; Patel R; Iyer D; Ram N; Gaba R; Balasubramanyam A; Hampe CS
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1040-4. PubMed ID: 24601691
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]